US 12097219
Single-domain antibodies against CLL1 and constructs thereof
granted A61KA61K2039/505A61K2239/29
Quick answer
US patent 12097219 (Single-domain antibodies against CLL1 and constructs thereof) held by Legend Biotech Ireland Limited expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Legend Biotech Ireland Limited
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K2239/29, A61K2239/31, A61K2239/38